Oncology & Cancer

Mistletoe as treatment for colon cancer?

(Medical Xpress)—Mistletoe has become an important symbol of Christmas but it also has the potential to play a vital role as an alternative therapy for Australian sufferers of colon cancer.

Genetics

Ageing linked to cancer

Ageing is an unavoidable part of life, and it is often accompanied by a number of age-related illnesses. One of the biggest diseases associated with ageing is cancer, which as a result is often referred to as a 'disease of ...

Oncology & Cancer

Central centrifugal cicatricial alopecia pathogenesis studied

(HealthDay)—Protease-activated receptor 2 (PAR-2), which is activated by cowhage, may play a role in central centrifugal cicatricial alopecia (CCCA), the most common cause of scarring hair loss in African-American women, ...

Oncology & Cancer

Perjeta approved for advanced breast cancer

(HealthDay) -- Perjeta (pertuzumab) has been approved by the U.S. Food and Drug Administration to treat people with HER2-positive late-stage breast cancer, the agency said in a news release.

Oncology & Cancer

Childhood cancer scars survivors later in life

Scars left behind by childhood cancer treatments are more than skin-deep. The increased risk of disfigurement and persistent hair loss caused by childhood cancer and treatment are associated with emotional distress and reduced ...

Diseases, Conditions, Syndromes

Hair loss pathology identified in pityriasis versicolor lesions

(HealthDay) -- Patients with pityriasis versicolor (PV) lesions may experience hair thinning and/or loss within the lesion, according to a study published online May 10 in the Journal of the American Academy of Dermatology.

Diseases, Conditions, Syndromes

Study to test new tinnitus 'treatment'

A new clinical trial is to test whether a pocket-sized device that uses sound simulation to reboot faulty 'wiring' in the brain could cure people with the debilitating hearing disorder tinnitus.

Medical research

US begins stem cell trial for hearing loss

US researchers have begun a groundbreaking trial to test the potential of umbilical cord blood transplants, a kind of stem cell therapy, to treat and possibly reverse hearing loss in infants.

page 21 from 27